Brief by Shorts91 Newsdesk / 02:41pm on 12 Mar 2025,Wednesday International
A study published in BMJ Mental Health reveals ADHD prescriptions in England have risen 18% yearly since 2020, increasing from 25 per 1,000 people to 41.55 in 2023/24. London saw the highest annual rise at 28%. Researchers attribute the surge to greater awareness via social media and increased psychological stress. Methylphenidate remains the most prescribed drug, while lisdexamfetamine saw a 55% annual increase. Experts urge policymakers to address regional and socioeconomic disparities in ADHD care access. The findings highlight growing demand amid long referral wait times.
